Home
Account
Research Tools & Data
Educate
Contribute
News
ETFs
Sectors
About
Subscribe
Login
Manage Account
Quote and Research
Stock Charts
Earnings Calendar
Technical Scans
Economic Calendar
Chart School
Tutorials
Learning Center
Submit Article
Join Blog Network
Chat Rooms
Rate Broker
Rate Software
About Us
Contact Us
Advertise With Us
Terms and Conditions
Momenta Pharmaceuticals Announces EMINENCE Trial Results to be Presented At the 21st Annual Transcatheter Cardiovascular Therapeutics (TCT) Meeting
Wednesday, September 09, 2009 8:02 AM
Email Article
Bookmark:
Font Size
Print Article
Sep. 9, 2009 (GlobeNewswire) -- Beverly Holley
617-395-5189
bholley@momentapharma.com
(Source: iStockAnalyst )
Bookmark:
Email Article
Print Article
Related Stories
Subscribe to
Email Alerts
US Stock Futures Point To Higher Open, Tiffany (NYSE: TIF) Eyed
As Bank Failures Grow, FDIC Options Narrow
Can U.S. Bank Stocks Double Again In 2010?
Credit Market Overview: Nov 24, 2009
Whatever Happened To Those Ethanol Companies?
Rate this Commentary
Comments
(0)
No Comments
Post Comment
Name:
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
Related Press Releases
Teva Files Amended Complaint Against Momenta/Sandoz to Include Infringement of Three COPAXONE®-Related Patents
Teva Comments on Mylan Paragraph IV Filing for COPAXONE®; Files Lawsuit Against Generic Filer for Patent Infringement
Momenta Pharmaceuticals, Inc. Announces Closing of Offering and Exercise of Over-Allotment Option
Momenta Pharmaceuticals Reports Financial Results for the Second Quarter of 2009
Momenta Pharmaceuticals Announces Date of Earnings Release and Conference Call for Second Quarter 2009 Financial Results
Advertisement
Popular Articles
Can U.S. Bank Stocks Double Again In 2010?
By:
Money Morning
Warning: You May Not Be Making As Much On Gold As You Think
By:
Money Morning
Bears In Trouble? Super Dividends
By:
Marc Courtenay
Ten Reasons For Buying Activision Blizzard (ATVI)
By:
Asif Suria
A Winning Investment Strategy
By:
Dividends4Life
Advertisement
Partner Center
{1}
##LOC[OK]##
{1}
##LOC[OK]##
##LOC[Cancel]##
{1}
##LOC[OK]##
##LOC[Cancel]##
Fundamental data is provided by
Zacks Investment Research
, market data is provided by
AlphaTrade.
, and Commentary and Press Releases provided by
Quotemedia
